Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus

Susanna Coers, Lisa Tanzer, Kathryn Jones

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Testosterone propionate (TP) administration coincident with facial nerve injury accelerates the recovery rate from facial muscle paralysis in the hamster. One mechanism by which TP could augment peripheral nerve regeneration is through glial fibrillary acidic protein (GFAP) regulation in the facial motor nucleus. In a previous study, axotomy alone induces increases in GFAP mRNA, with TP significantly attenuating the axotomy-induced increases in GFAP mRNA. In the present study, immunoblotting techniques were used to extend our previous GFAP mRNA studies to the protein level. Castrated male hamsters were subjected to a right facial nerve transection, with half of the animals receiving subcutaneous implants of 100% crystalline TP. The left facial motor nucleus of each animal served as an internal control. Postoperative survival times include Days 4, 7, and 14. In non-TP-treated animals, facial nerve transections alone increased GFAP levels at all time points, relative to internal controls. As previously observed at the mRNA level, TP treatment attenuated but did not eliminate the axotomy-induced increase in GFAP levels at all time points tested. These results suggest that the regulatory actions of gonadal steriods on GFAP expression manifested in parallel at the mRNA/protein levels.

Original languageEnglish (US)
Pages (from-to)55-63
Number of pages9
JournalMetabolic Brain Disease
Volume17
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Glial Fibrillary Acidic Protein
Facial Nerve
Cricetinae
Testosterone Propionate
Testosterone
Axotomy
Messenger RNA
Animals
Facial Nerve Injuries
Facial Muscles
Nerve Regeneration
Facial Paralysis
Propionates
Facial Nucleus
Peripheral Nerves
Immunoblotting
Muscle
Proteins
Crystalline materials
Recovery

Keywords

  • Astrocytes
  • Axotomy
  • Facial motoneuron
  • Glial fibrillary acidic protein
  • Peripheral nerve regeneration
  • Testosterone

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Neurology
  • Neuroscience(all)

Cite this

@article{9dd5d346e3894339b304641ac97abf97,
title = "Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus",
abstract = "Testosterone propionate (TP) administration coincident with facial nerve injury accelerates the recovery rate from facial muscle paralysis in the hamster. One mechanism by which TP could augment peripheral nerve regeneration is through glial fibrillary acidic protein (GFAP) regulation in the facial motor nucleus. In a previous study, axotomy alone induces increases in GFAP mRNA, with TP significantly attenuating the axotomy-induced increases in GFAP mRNA. In the present study, immunoblotting techniques were used to extend our previous GFAP mRNA studies to the protein level. Castrated male hamsters were subjected to a right facial nerve transection, with half of the animals receiving subcutaneous implants of 100{\%} crystalline TP. The left facial motor nucleus of each animal served as an internal control. Postoperative survival times include Days 4, 7, and 14. In non-TP-treated animals, facial nerve transections alone increased GFAP levels at all time points, relative to internal controls. As previously observed at the mRNA level, TP treatment attenuated but did not eliminate the axotomy-induced increase in GFAP levels at all time points tested. These results suggest that the regulatory actions of gonadal steriods on GFAP expression manifested in parallel at the mRNA/protein levels.",
keywords = "Astrocytes, Axotomy, Facial motoneuron, Glial fibrillary acidic protein, Peripheral nerve regeneration, Testosterone",
author = "Susanna Coers and Lisa Tanzer and Kathryn Jones",
year = "2002",
doi = "10.1023/A:1015415226799",
language = "English (US)",
volume = "17",
pages = "55--63",
journal = "Metabolic Brain Disease",
issn = "0885-7490",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus

AU - Coers, Susanna

AU - Tanzer, Lisa

AU - Jones, Kathryn

PY - 2002

Y1 - 2002

N2 - Testosterone propionate (TP) administration coincident with facial nerve injury accelerates the recovery rate from facial muscle paralysis in the hamster. One mechanism by which TP could augment peripheral nerve regeneration is through glial fibrillary acidic protein (GFAP) regulation in the facial motor nucleus. In a previous study, axotomy alone induces increases in GFAP mRNA, with TP significantly attenuating the axotomy-induced increases in GFAP mRNA. In the present study, immunoblotting techniques were used to extend our previous GFAP mRNA studies to the protein level. Castrated male hamsters were subjected to a right facial nerve transection, with half of the animals receiving subcutaneous implants of 100% crystalline TP. The left facial motor nucleus of each animal served as an internal control. Postoperative survival times include Days 4, 7, and 14. In non-TP-treated animals, facial nerve transections alone increased GFAP levels at all time points, relative to internal controls. As previously observed at the mRNA level, TP treatment attenuated but did not eliminate the axotomy-induced increase in GFAP levels at all time points tested. These results suggest that the regulatory actions of gonadal steriods on GFAP expression manifested in parallel at the mRNA/protein levels.

AB - Testosterone propionate (TP) administration coincident with facial nerve injury accelerates the recovery rate from facial muscle paralysis in the hamster. One mechanism by which TP could augment peripheral nerve regeneration is through glial fibrillary acidic protein (GFAP) regulation in the facial motor nucleus. In a previous study, axotomy alone induces increases in GFAP mRNA, with TP significantly attenuating the axotomy-induced increases in GFAP mRNA. In the present study, immunoblotting techniques were used to extend our previous GFAP mRNA studies to the protein level. Castrated male hamsters were subjected to a right facial nerve transection, with half of the animals receiving subcutaneous implants of 100% crystalline TP. The left facial motor nucleus of each animal served as an internal control. Postoperative survival times include Days 4, 7, and 14. In non-TP-treated animals, facial nerve transections alone increased GFAP levels at all time points, relative to internal controls. As previously observed at the mRNA level, TP treatment attenuated but did not eliminate the axotomy-induced increase in GFAP levels at all time points tested. These results suggest that the regulatory actions of gonadal steriods on GFAP expression manifested in parallel at the mRNA/protein levels.

KW - Astrocytes

KW - Axotomy

KW - Facial motoneuron

KW - Glial fibrillary acidic protein

KW - Peripheral nerve regeneration

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0035987826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035987826&partnerID=8YFLogxK

U2 - 10.1023/A:1015415226799

DO - 10.1023/A:1015415226799

M3 - Article

C2 - 12083337

AN - SCOPUS:0035987826

VL - 17

SP - 55

EP - 63

JO - Metabolic Brain Disease

JF - Metabolic Brain Disease

SN - 0885-7490

IS - 2

ER -